AURKA and neuroblastoma: Using MLN8237, which blocks the interaction between AURKA and MYCN, our group was able to demonstrate that AURKA inhibition is effective against NB in a MYCN-driven transgenic mouse model (TH-MYCN), in which high-level expression of MYCN is driven in neural crest by a tyrosine hydroxylase (TH) promoter (110).